Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningBone Marrow TransplantationLeukocytes, MononuclearBone MarrowTissue DonorsTransplantation, AutologousPeripheral Blood Stem Cell TransplantationBone Marrow CellsHematologic NeoplasmsTransplantation ChimeraStem CellsHistocompatibility TestingTreatment OutcomeGraft vs Leukemia EffectBusulfanT-LymphocytesMyeloablative AgonistsHematopoietic Stem CellsRemission InductionRecurrenceVidarabineGraft vs Tumor EffectGraft SurvivalHematopoietic Stem Cell MobilizationCells, CulturedLeukemiaMultiple MyelomaImmunosuppressive AgentsLeukemia, Myeloid, AcuteLymphocyte TransfusionWhole-Body IrradiationBone and BonesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRetrospective StudiesTime FactorsCombined Modality TherapyFlow CytometryLymphocytesCytomegalovirus InfectionsLymphocyte DepletionCord Blood Stem Cell TransplantationMyelodysplastic SyndromesGranulocyte Colony-Stimulating FactorSiblingsMinor Histocompatibility AntigensLiver TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisHistocompatibilityDisease-Free SurvivalSalvage TherapyAntilymphocyte SerumNeoplasm, ResidualVirus ActivationSurvival RateChimerismAntigens, CD34Anemia, AplasticLymphocyte ActivationCyclophosphamideMelphalanDonor SelectionAcute DiseaseAntineoplastic Combined Chemotherapy ProtocolsCytomegalovirusMesenchymal Stem Cell TransplantationHLA AntigensHepatic Veno-Occlusive DiseaseCell DifferentiationAntibodies, MonoclonalMonocytesPrimary MyelofibrosisAntigens, CDPolymerase Chain ReactionFollow-Up StudiesCytokinesCell TransplantationImmunosuppressionKidney TransplantationInterferon-gammaImmunophenotypingPrognosisBlood DonorsHematologic DiseasesLeukemia, MyeloidLiving DonorsTransplantation ImmunologyCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesAntineoplastic AgentsCell SeparationHematopoiesisLymphoproliferative DisordersMice, Inbred C57BLLymphocyte CountAntibodies, Neoplasm